PKCδ serves as a potential biomarker and therapeutic target for microglia-mediated neuroinflammation in Alzheimer's disease.
Du Y, Guo T, Hao Y, Li C, Tang L, Li X, Zhang X, Li L, Yao D, Xu X, Si H, Zhang J, Zhao N, Yu T, Zhao Y, Zhang W, Xu H.
Du Y, et al. Among authors: si h.
Alzheimers Dement. 2024 Aug;20(8):5511-5527. doi: 10.1002/alz.14047. Epub 2024 Jun 28.
Alzheimers Dement. 2024.
PMID: 38938161
Free PMC article.